Warhound
Warhound develops working dogs for military, law-enforcement and emergency-response teams.
$200MSeed
Participant8
8VC
Activity from announced rounds
Activity in this selectionBiotech
8VC invests in and builds technology companies in life sciences, healthcare, manufacturing, enterprise software, logistics and defence.
Its Build programme creates companies when the team identifies an opportunity without an existing business to back. This adds a company-formation route to its conventional investment activity, relevant to entrepreneurs developing a technology platform from the outset.
The firm also runs engineering and Bio-IT fellowships connecting emerging technical talent with its companies. These programmes reflect its emphasis on recruiting builders for sectors where software, scientific expertise and physical operations intersect.
Sources
- Rounds participated in
- 5
- Confirmed lead rounds
- 0 3 roles undisclosed
- New companies
- 5 First participation on record · 0 follow-on
- Funding in participating rounds
- $494M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
5 in this selectionBigHat Biosciences
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
$75MSeries C
ParticipantLatus Bio, Inc.
Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2
$97MSeries A
Role not disclosedAlloy Therapeutics
Drug discovery platforms and integrated development services for biotechnology and pharmaceutical partners.
$40MSeries E
Role not disclosedMendra
Develops and commercializes rare disease therapies using AI
$82MSeries A
Role not disclosed